Ricardo Yayá

2.2k total citations · 1 hit paper
26 papers, 1.5k citations indexed

About

Ricardo Yayá is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ricardo Yayá has authored 26 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Ricardo Yayá's work include Glioma Diagnosis and Treatment (12 papers), Brain Metastases and Treatment (6 papers) and Colorectal Cancer Treatments and Studies (3 papers). Ricardo Yayá is often cited by papers focused on Glioma Diagnosis and Treatment (12 papers), Brain Metastases and Treatment (6 papers) and Colorectal Cancer Treatments and Studies (3 papers). Ricardo Yayá collaborates with scholars based in Spain, France and United States. Ricardo Yayá's co-authors include Janet Bruner, Michael D. Prados, N C Yue, Henry S. Friedman, Sara Zaknoen, Jeffrey J. Olson, W.K. Alfred Yung, Margaret Dugan, Robert E. Albright and Michael Brada and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Ricardo Yayá

26 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse

1999 608 citations W.K. Alfred Yung, Michael D. Prados et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ricardo Yayá Spain	11	888	655	419	411	209	26	1.5k
Masayuki Kanamori Japan	28	1.5k 1.7×	509 0.8×	335 0.8×	677 1.6×	469 2.2×	164	2.5k
Sandrine Ostermann Switzerland	15	803 0.9×	458 0.7×	306 0.7×	539 1.3×	285 1.4×	23	1.7k
Jochen Tuettenberg Germany	20	494 0.6×	203 0.3×	357 0.9×	438 1.1×	265 1.3×	41	1.2k
Tareq A. Juratli Germany	21	675 0.8×	236 0.4×	138 0.3×	301 0.7×	207 1.0×	93	1.5k
M. Raphael Pfeffer Israel	20	158 0.2×	338 0.5×	600 1.4×	242 0.6×	172 0.8×	51	1.5k
Akshal Patel United States	9	666 0.8×	304 0.5×	172 0.4×	277 0.7×	154 0.7×	22	1.2k
Yazmín Odia United States	20	569 0.6×	217 0.3×	205 0.5×	446 1.1×	195 0.9×	89	1.2k
Ravi D. Rao United States	12	338 0.4×	130 0.2×	588 1.4×	276 0.7×	84 0.4×	19	1.2k
Ricardo J. Komotar United States	19	587 0.7×	304 0.5×	130 0.3×	202 0.5×	120 0.6×	79	1.4k
Friedrich-Wilhelm Kreth Germany	26	1.4k 1.6×	734 1.1×	122 0.3×	225 0.5×	265 1.3×	56	2.0k

Countries citing papers authored by Ricardo Yayá

Since Specialization

Citations

This map shows the geographic impact of Ricardo Yayá's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ricardo Yayá with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ricardo Yayá more than expected).

Fields of papers citing papers by Ricardo Yayá

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ricardo Yayá. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ricardo Yayá. The network helps show where Ricardo Yayá may publish in the future.

Co-authorship network of co-authors of Ricardo Yayá

This figure shows the co-authorship network connecting the top 25 collaborators of Ricardo Yayá. A scholar is included among the top collaborators of Ricardo Yayá based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ricardo Yayá. Ricardo Yayá is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

López, Carlos, Mariona Calvo, Juan Carlos Cámara, et al.. (2024). SEOM-GEMCAD-TTD clinical guidelines for the management of hepatocarcinoma patients (2023). Clinical & Translational Oncology. 26(11). 2800–2811. 2 indexed citations

Salgado, Mercedes, et al.. (2017). Management of unresectable, locally advanced pancreatic adenocarcinoma. Clinical & Translational Oncology. 20(2). 113–118. 2 indexed citations

Machado, Isidro, Miriam Valera‐Alberni, Fernando Martínez de Juan, et al.. (2016). Histological factors predicting loco-regional lymph node metastasis in early invasive colorectal adenocarcinoma pT1. Gastroenterología y Hepatología (English Edition). 39(1). 1–8. 5 indexed citations

Machado, Isidro, Miriam Valera‐Alberni, Fernando Martínez de Juan, et al.. (2015). Estudio de factores histológicos predictivos de metástasis ganglionar locorregional en adenocarcinoma colorrectal mínimamente invasivo pT1. Gastroenterología y Hepatología. 39(1). 1–8. 8 indexed citations

Custodio, Ana, Juan Moreno‐Rubio, Jorge Aparicio, et al.. (2014). Pharmacogenetic Predictors of Outcome in Patients with Stage II and III Colon Cancer Treated with Oxaliplatin and Fluoropyrimidine-Based Adjuvant Chemotherapy. Molecular Cancer Therapeutics. 13(9). 2226–2237. 10 indexed citations

Custodio, Ana, Juan Moreno‐Rubio, Jorge Aparicio, et al.. (2013). Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study. Annals of Oncology. 25(2). 398–403. 44 indexed citations

Yayá, Ricardo, et al.. (2011). Glioblastoma: changing expectations?. Clinical & Translational Oncology. 13(4). 240–248. 6 indexed citations

Berrocal, Alfonso, Pedro Pérez Segura, Carmen Balañá, et al.. (2009). Extended-schedule dose-dense temozolomide in refractory gliomas. Journal of Neuro-Oncology. 96(3). 417–422. 46 indexed citations

Yayá, Ricardo, Maria F. Paz, I. Rojas-Marcos, et al.. (2005). CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas. Neurochirurgie. 51(1). 51–51. 9 indexed citations

10.

Verger, E., Miguel Gil‐Gil, Ricardo Yayá, et al.. (2004). Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: A phase II randomized trial. International Journal of Radiation Oncology*Biology*Physics. 61(1). 185–191. 163 indexed citations

11.

Paz, Maria F., Ricardo Yayá, I. Rojas-Marcos, et al.. (2004). CpG Island Hypermethylation of the DNA Repair Enzyme Methyltransferase Predicts Response to Temozolomide in Primary Gliomas. Clinical Cancer Research. 10(15). 4933–4938. 205 indexed citations

12.

Yayá, Ricardo, et al.. (2003). Proteína S100 en tumores del Sistema nervioso central. Revista de Neurología. 36(11). 1011–1011. 7 indexed citations

13.

Sanson, Marc, Mariasanta Napolitano, Ricardo Yayá, et al.. (2000). Second Line Chemotherapy with Docetaxel in Patients with Recurrent Malignant Glioma: A Phase II Study. Journal of Neuro-Oncology. 50(3). 245–249. 37 indexed citations

14.

Yung, W.K. Alfred, Michael D. Prados, Ricardo Yayá, et al.. (1999). Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse. Journal of Clinical Oncology. 17(9). 2762–2762. 608 indexed citations breakdown →

15.

Yayá, Ricardo, et al.. (1998). Dolicoectasia vertebrobasilar. Revista de Neurología. 26(149). 143–143. 6 indexed citations

16.

Villà, S., Núria Viñolas, E. Verger, et al.. (1998). Efficacy of radiotherapy for malignant gliomas in elderly patients. International Journal of Radiation Oncology*Biology*Physics. 42(5). 977–980. 54 indexed citations

17.

Vallés, Juana, et al.. (1993). Effects of dipyridamole, pentoxifylline or dipyridamole plus pentoxifylline on platelet reactivity in patients with ischemic cerebrovascular insufficiency. Thrombosis Research. 72(3). 219–229. 5 indexed citations

18.

Aznar, Justo, et al.. (1993). Sneddon's syndrome and antiphospholipid antibodies. Thrombosis Research. 69(6). 555–560. 11 indexed citations

19.

Lago, Aída, et al.. (1989). [Opsoclonic cerebellar disease. A paraneoplastic syndrome sensitive to chlormethiazole].. PubMed. 6(5). 260–2. 2 indexed citations

20.

Santos, M. Teresa, Vicenta Martı́nez-Sales, Juana Vallés, et al.. (1985). Prostacyclin production of rat aorta “in vitro” is increased by the combined action of dipyridamole plus pentoxifylline. Prostaglandins. 29(1). 113–122. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact